Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 311 - 315 out of 326
Ecker, G, Chiba, P, Schaper, K-J & Hitzler, M 1998, 'A combined Hansch/Free-Wilson approach as predictive tool in QSAR studies on propafenone-type modulators of multidrug resistance', Archiv der Pharmazie, vol. 331, pp. 233-240.
Fleischhacker, W, Ecker, G & Wolschann, KP 1998, 'A quantum chemical study of levcromakalim', Monatshefte für Chemie, vol. 129, pp. 633-642.
Jäger, W & Ecker, G 1998, 'Metabolism of the new MDR-modifier AM05 by human liver microsomes', Scientia Pharmaceutica, vol. 66, pp. 159-168.
Ecker, G, Hitzler, M & Chiba, P 1998, 'Studies on propafenone-type modulators of multidrug resistance VI: synthesis and pharmacological activity of compounds with varied spacer length between the central aromatic ring and the nitrogen atom', Il Farmaco, vol. 53, pp. 357-364.
Ecker, G, Chiba, P & Hitzler, M 1998, 'Studies on propafenone-type modulators of mutlidrug resistance VIII: Synthesis and pharmacological activity of indanone analogues', Scientia Pharmaceutica, vol. 66, pp. 147-168.
Projects
Molecular Drug Targets
Hering, S. (Project Lead), Ecker, G. (Co-Lead), Maulide, N. (Co-Lead), Weinzinger, A. (Co-Lead) & Gonzalez Herrero, L. (Co-Lead)
1/12/10 → 31/12/22
Project: Research funding